Deninta SC 60 mg PFS
226,65$
158,59$
Deninta SC 60 mg PFS is a targeted therapy designed to combat osteoporosis in men and postmenopausal women who are at an elevated risk of fractures and have not had success with other osteoporosis treatments. This medication is particularly beneficial for individuals experiencing bone loss due to prostate cancer in men and breast cancer in women, especially those undergoing therapies that can weaken bones. By promoting bone density and strength, Deninta SC significantly lowers the likelihood of fractures in patients with conditions such as bone cancer and multiple myeloma, a blood cancer affecting the bone marrow. It’s crucial to note that while Deninta SC is effective, patients should be monitored for potential side effects and consult their healthcare provider if any adverse reactions occur. With its specialized formulation, Deninta SC offers a vital option for those needing effective management of bone health in the face of serious medical conditions. As a part of a comprehensive treatment plan, this medication aims to enhance quality of life by safeguarding against the debilitating impacts of weakened bones. Always discuss with your healthcare professional to ensure this treatment aligns with your specific health needs.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Deninta sc 60 mg pfs is indicated for the treatment of osteoporosis in men and postmenopausal women at a high risk for fractures. This medication helps increase bone density, reducing the likelihood of bone-related complications. It is particularly beneficial for individuals who have not had a satisfactory response to other osteoporosis treatments. By enhancing bone strength, Deninta sc 60 mg pfs plays a crucial role in managing this condition.
• Deninta sc 60 mg pfs is utilized in patients with osteolytic bone metastases associated with solid tumors, such as prostate and breast cancer. This medication addresses the issue of bone loss that can occur due to cancer treatments. By mitigating the effects of treatments that lead to weakened bones, Deninta sc 60 mg pfs helps maintain bone integrity. This is essential for improving the overall quality of life for patients facing these serious health challenges.
• The use of Deninta sc 60 mg pfs extends to those experiencing bone density loss due to specific cancer therapies. Men undergoing treatment for prostate cancer and women receiving care for breast cancer can benefit from this medication. Deninta sc 60 mg pfs aids in counteracting the bone-depleting effects of certain drugs, thus preserving skeletal health. This targeted approach is vital for patients who require ongoing cancer management while minimizing the risk of bone-related issues.
Benefits
Deninta SC 60 mg PFS has been shown to be effective in reducing the risk of fractures in patients with osteoporosis and increasing bone density and strength, resulting in a lower risk of fractures in the spine, hip, and other bones. Deninta SC 60 mg is effective in reducing the risk of fractures in patients with bone metastases (spread of cancer to the bones).
Side Effects
Anti-resorptive Drug Deninta may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Arm or leg pain
• Joint pain
• Muscle or bone pain
• Constipation,
• Abdominal discomfort
• Hair loss
• Skin rash
• Tingling, pain, or numbness that moves down your leg
Common Side Effects
• Upper respiratory tract infection
• Frequent or painful urination, blood in urine, inability to hold urine
• Musculoskeletal
• Severe leg or joint pain
How To Use
Deninta SC 60 mg PFS can be administered to you subcutaneously (under the skin) by a doctor or nurse. You should also take calcium and vitamin D supplements while being on treatment with Anti-resorptive Drug Deninta. Your doctor will decide the correct dose and duration for you depending on your age, body weight and disease condition.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Deninta SC 60 mg PFS. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Deninta SC 60 mg PFS should be used with caution in patients having severe kidney problems. Patients with severe kidney impairment (creatinine clearance < 30 mL/min) or receiving dialysis are at greater risk of developing hypocalcaemia. Consult your doctor before receiving Deninta SC 60 mg.
• Breastfeeding: It is not known whether Deninta SC 60 mg PFS passes into breast milk. If you are breastfeeding and taking Deninta SC 60 mg it is important to talk to your doctor about the potential risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Deninta SC 60 mg PFS should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Deninta SC 60 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Deninta SC 60 mg PFS may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Deninta SC 60 mg PFS may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Denosumab Injection 60 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Deninta SC 60 mg PFS has no or negligible influence on the ability to drive and use machines.